NewHealthcare Platforms

AI is not just enhancing diagnostics and streamlining operations but paving the way for a complete reinvention of how care is delivered. In today's newsletter, we explore other industries' technological transformation journeys for lessons on how we can lead the way! ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin ? #artificialintelligence #ai #valuebasedcare #healthcare

Forward, an ambitious startup promising to revolutionize primary care with AI and automation, has shut down. In today's newsletter, I dive deep into what went wrong and why tech-driven healthcare disruption is far more complex than most realize. From ambitious CarePods to the unsustainable business model, Forward's story is a lesson for all healthcare innovators. Let's explore the key lessons from Forward’s downfall! ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin ? #artificialintelligence #ai #valuebasedcare #healthcare

I'm out of town today, so in lieu of a newsletter, I'll including Microsoft's Research Forum Brief article from earlier this year. Enjoy! ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition. #healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

In today's newsletter, we dive into a fascinating journey of how our understanding of diseases like diabetes has evolved through centuries, driven by new tools and techniques that have pushed the boundaries of medicine. I explore how revolutionary new technologies such as spatial transcriptomics and single-cell analysis are not only expanding our insights into disease but creating an urgent need for a fundamental redesign of the specialization model of delivering care. Let's explore how a new model integrating AI with human expertise can create the next generation of healthcare experiences and breakthrough outcomes. ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

The unprecedented rate of progress of AI is straining our capacity as individuals and organizations to adapt! To successfully navigate the opportunities and challenges presented by AI’s progress, we need to understand the stages of AI development. In today’s newsletter, I will discuss a fascinating 5-stage AI progress framework developed by OpenAI, the company that for all intents and purposes started the current avalanche of AI products and services. From conversational AI to full-fledged artificial general intelligence (AGI), this model provides a roadmap for the decade or so that started in November 2022 with the release of ChatGPT and that will likely culminate a few years from now with AI becoming an integral part of every aspect of life. Today’s installment likely kicks off a series of articles where we will explore different aspects and applications of this model, with a special emphasis on Stage 3: AI Agent, the stage that is just starting. We will also examine how these agents could transform healthcare—how they will impact patient care, fit within our current regulatory frameworks and reimbursement system. ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

In this edition of our healthcare newsletter, we explain digital twin technology and its healthcare applications. By leveraging real-time data integration, advanced analytics, and virtual simulations, digital twins can enhance patient care, enable proactive medical event prediction, optimize clinical operations, and enhance medical training. We will take a closer look at the applications and benefits of digital twins and discuss how they will impact the future of healthcare. ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

Physicists and Chemists did NOT win the 2024 Nobel Prizes in Physics and Chemistry! Both prizes were awarded to AI researchers! Geoffrey Hinton and John Hopfield won the Nobel Prize in Physics for their work that provided the foundation of artificial neural networks which are the building blocks of today’s AI revolution! But more relevant to healthcare, was Demis Hassabis, co-founder and CEO of Google DeepMind, being awarded the Nobel Prize in Chemistry. A remarkable achievement considering he is not a trained chemist! His win, alongside his DeepMind colleague John Jumper, highlights the potential of artificial intelligence (AI) to enable non-specialists to perform at the highest levels in fields in which they have little or no training. In today’s newsletter, I will argue that AI’s power to enable non-specialists to achieve the highest level of performance in fields where they have no extensive training, goes beyond chemistry. Specifically, AI will enable non-physicians and non-specialists to diagnose and treat a broad spectrum of condition which today require many years of training and experience! I will try to anticipate the opportunities and challenges that this might pose to those in healthcare and to society. ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

A recent study from some of America's most prestigious academic medical centers including Stanford University, Harvard Medical School, and the University of Virginia compared the diagnostic performance of physicians using GPT-4 against those using conventional resources. While access to the LLM didn't significantly improve overall diagnostic reasoning, it showed promising results in efficiency and final diagnosis accuracy (those using GPT-4 scored 76% while those not using GPT-4 scored 74%). Surprisingly, however, GPT-4 alone outperformed both groups of human physicians, scoring 92%! In today's newsletter, we discuss the implications of these results. ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

The current business models of the healthcare industry including hospitals, doctors, pharmaceutical companies, and health insurers are built on a foundation of treating disease within the limitations of human intelligence, current technology and productivity norms. They thrive on the volume of services provided, the number of patients treated, and the complexity of the conditions they manage. But today's technological revolution, various aspects of which I've been covering in this newsletter, will significantly improve efficiency, productivity, and patient outcomes. The very success of these innovations will threaten the financial viability of the organizations that have long been the backbone of our healthcare system and the largest employers in our economy! ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare

In our last newsletter, we delved into how AI-powered consumer technology is disrupting healthcare, with tech giants like Apple and Google, and traditional medical technology companies like Dexcom and Abbott making significant strides in integrating health monitoring and medical capabilities into their products. From smartwatches detecting irregular heart beats (arrhythmia) to continuous blood sugar monitors available over-the-counter, these developments signify a growing trend of consumer devices crossing over into the realm of medical devices. Today, we'll explore how this shift is part of a broader movement towards consumer-directed wellness, drawing parallels to the transformation that occurred in the financial services industry. ___________________________________________ Dr. Sam Basta is a pioneer of Value-Based Care Platforms with two decades experience building value-based medical technology solutions and leading award-winning care delivery transformation at payer and provider organizations. His company, NewHealthcare Platforms, provides consulting services to the Medical Device industry specializing in value-based solution design and go-to-market execution. His thought leadership articles and weekly newsletter are widely followed (25,000+) gaining LinkedIn Top Voice recognition.?#healthcareonlinkedin #artificialintelligence #ai #valuebasedcare #healthcare